Experts from the University of Nebraska and the Texas Biomedical Research Institute are recommending scientists study the potential use of cannabis-derived CBD in anti-viral therapies, due to its known anti-inflammatory properties Forbes contributor Emily Earlenbaugh joins CBSN's Lana Zak with the details.
